Kocak Farma
Koçak Pharma was established in 1971. Manufactures pharmaceutical products and pharmaceutical agents.
In 2000, Koçak Pharma was established on an area of 140.000 m2 in the Çerkezköy Organized Industrial Zone in Istanbul.
Kocak, Turkey's largest enclosed area of pharmaceutical production plant, is celebrating its 48 anniversary this year.
In Koçak Pharma Group; approximately 1,500 people are employed in production, sales and administrative departments.
Koçak Pharma is 222th of Istanbul Chamber of Industry of Turkey's top 500 industrial enterprises.
Koçak Pharma is an R & D center approved by the Ministry of Science, Industry and Trade. 70 experts and scientists are doing researches.
Koçak Pharma pharmaceutical production facilities have special production areas approved by the European Union GMP.
Our company has been focusing on women-birth, urology, chest diseases (tuberculosis), cardiology, oncology and general health protection products.
Koçak Pharma is able to produce in all pharmaceutical forms in these special production areas.
Kocak Pharma biosimilars products, cancer products, soft capsule products, products sterile cartridges, ampoules and vials, and lyophilized products are in the form of sterile syringes, ready to use products are manufactured for the first time in Turkey.
Koçak Pharma is the only company that is meeting the need of tuberculosis medicine of the Ministry of Health for 46 years.
Kocak Pharma, has 85 product licenses in the field of oncology and oncology produces of the raw materials that covers the need of Turkey.
Koçak Pharma has the capacity and product variety to meet the needs of our country in Oncology field.
With its wide product portfolio in oncology, it is one of the leading companies in the world.
In 2011, Koçak Pharma received a gold mortar pharmacy award with the Production of oncology drugs and raw materials.
In 2012, Koçak Farma became the finalist in the TUBITAK 10Technology Awards, in the large-scale company process category with the project of Enoxaparin Sodium Active Ingredient to reduce coagulation in blood.
In 2013, Koçak Pharma received the Golden Pharmacy Pharmacy Award with the project of Production of Insulin as an Active Substance and End Product for the ”Biosimilar Product Used in Diabetes Treatment.
In 2014, Koçak Pharma became the finalist in the large-scale company process category of the TÜBİTAK 11.tecnology awards with their project; Production of biosimilar product insulin as an active ingredient and end product in the treatment of diabetes.
Koçak Pharma production facilities have received the European Union GMP (Good Manufacturing Practices) certificate of conformity, audited by the European Union Health Authorities.
Koçak Pharma exports its products produced in European Union GMP approved facilities to more than 40 countries, including EU countries such as Germany, France, Italy, Spain, South Korea and Australia.
Apart from the European Union, Koçak Pharma, which has been inspected and approved by the authorities of Iraq, Iran, Libya, Ukraine and South Africa, also exports to these countries.
Koçak Pharma conducts R & D studies for multinational generic companies, prepares registration dossiers and makes contract manufacturing.
Koçak Pharma received ISO 9001 quality management system certification, ISO 14001 Environmental management system certification, OHSAS 18001 work and health protection management system certificates from German TÜV RHEİNLAND.
In 2014, our company has received an investment incentive for the production of biotechnological drugs in Çerkezköy OSB with a total value of 1.100.000.000 TL.
Turkey's first biotech drug production facility laid the foundation on September 24, 2014 by Science, Industry and Technology Minister Fikri IŞIK laid in the Çerkezköy Organized Industrial Zone. Within the scope of this project, analog insulin, monoclonal antibodies (Mab), bacterial, viral and recombinant vaccines are produced in our country with the management of recombinant DNA technology (cloning).